Royalty Pharma Sub-Manager, LLC
- SEC CIK
- 0002081668
- Latest filing
- Aug 21, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 21, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 4
- 0 vs. Q1 2026
- Portfolio value
- $241.9M
- +$69.2M (+40.0%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CYTKCytokinetics Inc | COM NEW | 980,392 | $83.5M | 34.5% | 00.0% | Unchanged | History |
| ZBIOZenas BioPharma, Inc. | COM | 2,388,150 | $60.6M | 25.1% | 00.0% | Unchanged | History |
| KLRAKailera Therapeutics, Inc. | COMMON STOCK | 2,455,357 | $54.1M | 22.4% | +2,455,357 | New | History |
| BHVNBiohaven Ltd. | COM | 2,936,507 | $43.7M | 18.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.